stockmarketproxy
/
EWNYSESEC EDGAREDGAR

Edwards Lifesciences Corp

Orthopedic, Prosthetic & Surgical Appliances & Supplies·IRVINE, CA·FY end 12/31·CIK 1099800
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$6.1B$1.4B$6.0B$5.4B$5.2B
Gross Profit$4.7B$1.1B$4.6B$4.3B$4.0B
Operating Income$1.3B$1.4B$1.5B$1.7B$1.7B
Net Income$1.1B$385.6M$1.4B——
Operating CF$1.6B$542.3M$895.8M$1.2B$1.7B
Capex$260.2M$252.4M$253.0M$244.6M$325.8M
Free Cash Flow$1.3B$289.9M$642.8M$973.6M$1.4B
Buybacks$893.4M$1.2B$879.6M$1.7B$512.8M
Dividends——————
Gross Margin78.0%78.9%77.0%79.9%76.1%
Operating Margin20.8%99.5%25.5%32.5%32.3%
Net Margin17.7%27.8%23.4%——
FCF Margin22.0%20.9%10.7%18.1%26.9%
R&D / Revenue17.8%76.0%17.8%17.6%17.3%
Effective Tax17.0%9.8%12.4%13.9%11.7%
Debt / Equity0.060.060.090.100.10
Buybacks / FCF66.9%399.9%136.8%177.4%36.5%

Peer comparison

Orthopedic, Prosthetic & Surgical Appliances & Supplies · 5 peers
CEO Pay Ratio
EW
194:1
ISRG
147:1
ALGN
610:1
STE
151:1
MSA
88:1
ZBH
200:1
CEO total comp
EW
$17M
ISRG
$21M
ALGN
$19M
STE
$11M
MSA
$6M
ZBH
—
Net Margin
EW
17.7%
ISRG
28.4%
ALGN
10.2%
STE
11.3%
MSA
4.6%
ZBH
8.6%